Majewski S, Blaszczyk M, Wasik M, Jablonska S
Br J Dermatol. 1987 Jan;116(1):1-8. doi: 10.1111/j.1365-2133.1987.tb05784.x.
Peripheral blood mononuclear cells from 63 patients with systemic scleroderma, including incipient or prodromal acrosclerosis, and from 20 healthy individuals were tested for natural killer (NK) cell activity and antibody-dependent cell cytotoxicity in a 4 h 51Cr release assay using K562 and L1210 cell lines respectively. In patients with systemic scleroderma natural killer cell activity was significantly decreased compared with the controls. NK cell activity was markedly lowered in patients with diffuse scleroderma and in transitional form acrosclerosis-diffuse scleroderma, and was normal in cases of acrosclerosis and/or CREST syndrome and in cases of prodromal or incipient scleroderma. Antibody-dependent cell cytotoxicity of mononuclear cells from the systemic scleroderma patients was within the normal range. The lowered natural killer cell activity correlated with the severity of systemic scleroderma, in terms of the extent of skin and organ involvement.
对63例系统性硬化症患者(包括早期或前驱性肢端硬化症患者)以及20名健康个体的外周血单个核细胞,分别使用K562和L1210细胞系,通过4小时51Cr释放试验检测自然杀伤(NK)细胞活性和抗体依赖性细胞毒性。与对照组相比,系统性硬化症患者的自然杀伤细胞活性显著降低。弥漫性硬化症患者以及肢端硬化症 - 弥漫性硬化症过渡型患者的NK细胞活性明显降低,而肢端硬化症和/或CREST综合征患者以及前驱性或早期硬化症患者的NK细胞活性正常。系统性硬化症患者单核细胞的抗体依赖性细胞毒性在正常范围内。就皮肤和器官受累程度而言,自然杀伤细胞活性降低与系统性硬化症的严重程度相关。